Xionggui Decoction alleviates heart failure in mice with myocardial infarction by inhibiting oxidative stress-induced cardiomyocyte apoptosis

doi:10.12122/j.issn.1673-4254.2024.07.22

Abstract

Abstract:

Objective To explore the protective effect of Xionggui Decoction against cardiac myopathy in a mouse model of heart failure following myocardial infarction (MI) and explore the underlying mechanism. Methods We searched TCMSP, GeneCards, and CTD databases for the targets of active ingredients Xionggui Decoction and heart failure, and the intersecting targets were analyzed with GO and KEGG pathway enrichment analysis using DAVID database. In a mouse model of heart failure following acute MI induced by coronary artery ligation, the cardiac protective effects of 3 g/kg Xionggui Decoction were evaluated by assessing cardiac function, cardiac myopathy and ventricular remodeling of the mice using HE staining, Masson staining, RT-qPCR, and immunohistochemistry. We also tested the effect of Xionggui Decoction at 50 and 100 μg/mL on tert-butylhydrogen peroxide (TBHP)-induced apoptosis of H9C2 cells using CCK8 assay, detection kits for ROS, MDA, SOD, JC-1 and Hoechst 33342/PI staining. Results Network pharmacological analysis identified 62 potential targets of Xionggui Decoction for treatment of heart failure, and the core targets included PTGS2, ESR1, caspase-3, PPARG, HSP90AA1, BCL2, JUN, and GSK3B, which were involved in cell apoptosis and the AGE-RAGE, P53, PI3K-Akt, and VEGF signaling pathways. In the mouse models of heart failure, treatment with Xionggui Decoction significantly alleviated cardiac myopathy and ventricular remodeling, obviously improved heart function of the mice, lowered myocardial expressions of caspase-3 and BAX, and enhanced the expression of BCL2. In H9C2 cells, Xionggui Decoction significantly alleviated TBHP-induced cell apoptosis by inhibiting oxidative stress in the cells. Conclusion Xionggui Decoction can alleviate myocardial injury and improve cardiac function in mice with heart failure following acute MI possibly by inhibiting cardiomyocyte apoptosis induced by oxidative stress.

Key words: Xionggui Decoction, heart failure, network pharmacology, apoptosis, oxidative stress

Zhijun REN, Jianxin DIAO, Yiting WANG. Xionggui Decoction alleviates heart failure in mice with myocardial infarction by inhibiting oxidative stress-induced cardiomyocyte apoptosis[J]. Journal of Southern Medical University, 2024, 44(7): 1416-1424.

Figures/Tables 9

Fig.2 GO and KEGG pathway enrichment analysis of the potential targets.

Fig.3 Xionggui Decoction improves heart function of the mice with heart failure. A: Left ventricular end-systolic dimension (LVEDs). B: Left ventricular end-diastolic dimension (LVEDd). C: Left ventricular ejection fraction (LVEF). D: Left ventricular fractional shortening (LVFS). ##P<0.01 vs Sham group; *P<0.05, **P<0.01 vs Model group.

Fig.4 Xionggui Decoction alleviates myocardial damage in mice with heart failure. A: Heart weight/body weight ratio. B-D: Serum LDH, CK, and AST levels. ##P<0.01 vs Sham group; *P<0.05, **P<0.01 vs Model group.

Fig.5 Xionggui Decoction alleviates myocardial necrosis and inflammation in mice with heart failure. The green arrows indicate the inflammatory cells (scale bar: 100 μm).

Fig.6 Xionggui Decoction alleviates myocardial fibrosis in mice with heart failure. A: Masson staining of the myocardial tissue. B: Collagen volume fraction. C: Relative expression of Collagen I. D: Relative expression of Collagen III. ##P<0.01 vs Sham group; **P<0.01 vs Model group.

Fig.7 Xionggui Decoction alleviates myocardial cell apoptosis in mice with heart failure. A: Immunohistochemical analysis. B: Relative expression of BAX. C: Relative expression of BCL2. D: Relative expression of caspase-3. #P<0.05, ##P<0.01 vs Sham group; **P<0.01 vs Model group.

Fig.8 Xionggui Decoction alleviate H9C2 cell injury induced by oxidative stress. A: Viability of H9C2 cells incubated with different concentrations of Xionggui Decoction (XGT). B: Viability of H9C2 cells incubated with different concentrations of TBHP. C: Viability of H9C2 cells incubated with different concentrations of XGT (50 and 100 µg/mL), followed by treatment with TBHP (200 μmol/L). ##P<0.01 vs Control group; *P<0.05, **P<0.01 vs TBHP group.

Fig.9 Xionggui Decoction protects H9C2 cells from TBHP-induced oxidative stress. A: Reactive oxygen species (ROS) levels. B: Malondialdehyde (MDA) content. C: Superoxide dismutase (SOD) activity. ##P<0.01 vs Control; *P<0.05 vs TBHP; **P<0.01 vs TBHP.

Fig.10 Xionggui Decoction alleviates TBHP-induced H9C2 cell apoptosis. A: Hoechst 33342/PI fluorescent staining. B: JC-1 staining. ##P<0.01 vs Control; **P<0.01 vs TBHP.

References 20

1	Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: a report from the American heart association[J]. Circulation, 2021, 143(8): e254-e743.
2	Zhao W, Zhao J, Rong J. Pharmacological modulation of cardiac remodeling after myocardial infarction[J]. Oxid Med Cell Longev, 2020, 2020: 8815349.
3	Chen ZJ, Zhang C, Gao F, et al. A systematic review on the rhizome of Ligusticum chuanxiong Hort. (Chuanxiong)[J]. Food Chem Toxicol, 2018, 119: 309-25.
4	Lv XF, Wen RQ, Liu K, et al. Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy[J]. Front Cardiovasc Med, 2022, 9: 1047700.
5	Huang CY, Kuo WW, Kuo CH, et al. Protective effect of Danggui (Radix Angelicae Sinensis) on angiotensin II-induced apoptosis in H9c2 cardiomyoblast cells[J]. BMC Complement Altern Med, 2014, 14: 358.
6	王心意, 鞠建庆, 樊懿萱, 等. 基于数据挖掘的国家级名老中医治疗冠心病用药规律研究[J]. 辽宁中医药大学学报, 2021, 23(3): 159-63. DOI: 10.13194/j.issn.1673-842x.2021.03.036
7	谢凌鹏, 周楚莹, 吕志平. 基于网络药理学探讨黄连抗肝细胞癌的作用机制[J]. 中医肿瘤学杂志, 2022, 4(1): 29-35. DOI: 10.19811/j.cnki.ISSN2096-6628.2022.01.006
8	Chen GH, Xu HL, Xu T, et al. Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways[J]. Phytomedicine, 2022, 104: 154277.
9	Branch of Cardiovascular Physicians, Chinese Medical Doctor Association;China Cardiovascular Health Alliance;The Expert Consensus Working Group on the Prevention and Treatment of Heart Failure After Myocardial Infarction. 2020心肌梗死后心力衰竭防治专家共识[J]. 中国循环杂志, 2020, 35(12): 1166-80.
10	Teringova E, Tousek P. Apoptosis in ischemic heart disease[J]. J Transl Med, 2017, 15(1): 87.
11	Li WX, Tang YP, Chen YY, et al. Advances in the chemical analysis and biological activities of Chuanxiong[J]. Molecules, 2012, 17(9): 10614-51.
12	董培良, 李慧, 韩华. 当归及其药对的研究进展[J]. 中医药信息, 2019, 36(2): 127-30. DOI: 10.19656/j.cnki.1002-2406.190063
13	Zhou Z, Chen B, Chen S, et al. Applications of network pharmacology in traditional Chinese medicine research[J]. Evid Based Complement Alternat Med, 2020: 1646905.
14	Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis[J]. J Cell Biol, 2022, 221(6): e202201159.
15	Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch[J]. Nat Rev Cancer, 2002, 2(9): 647-56.
16	Elmore S. Apoptosis: a review of programmed cell death[J]. Toxicol Pathol, 2007, 35(4): 495-516.
17	Perelman A, Wachtel C, Cohen M, et al. JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry[J]. Cell Death Dis, 2012, 3(11): e430.
18	Panth N, Paudel KR, Parajuli K. Reactive oxygen species: a key hallmark of cardiovascular disease[J]. Adv Med, 2016: 9152732.
19	Brieger K, Schiavone S, Miller FJ, et al. Reactive oxygen species: from health to disease[J]. Swiss Med Wkly, 2012, 142: w13659.
20	Krylatov AV, Maslov LN, Voronkov NS, et al. Reactive oxygen species as intracellular signaling molecules in the cardiovascular system[J]. Curr Cardiol Rev, 2018, 14(4): 290-300.

[1]	Jinjin WANG, Wenfei CUI, Xuewei DOU, Binglei YIN, Yuqi NIU, Ling NIU, Guoli YAN. Euonymus alatus delays progression of diabetic kidney disease in mice by regulating EGFR tyrosine kinase inhibitor resistance signaling pathway [J]. Journal of Southern Medical University, 2024, 44(7): 1243-1255.
[2]	Linyue WANG, Wenyue QI, Jihua GAO, Maosheng TIAN, Jiancheng XU. Tongyangxiao Lotion promotes postoperative wound healing in a rat model of anal fistula by downregulating inflammatory factors and suppressing inflammation [J]. Journal of Southern Medical University, 2024, 44(7): 1256-1265.
[3]	Wenxiang ZHANG, Huixian GU, Pengde CHEN, Siyu WU, Hongyan MA, Lan YAO. Compound Yuye Decoction protects diabetic rats against cardiomyopathy by inhibiting myocardial apoptosis and inflammation via regulating the PI3K/Akt signaling pathway [J]. Journal of Southern Medical University, 2024, 44(7): 1306-1314.
[4]	Yan HUANG, Lulu QIN, Shaoxing GUAN, Yanping GUANG, Yuru WEI, Ailing CAO, Dongmei LI, Guining WEI, Qibiao SU. Therapeutic mechanism of aqueous extract of Semiliquidambar cathayensis Chang root for pancreatic cancer: the active components, therapeutic targets and pathways [J]. Journal of Southern Medical University, 2024, 44(7): 1336-1344.
[5]	Mengdong ZHENG, Yan LIU, Jiaojiao LIU, Qiaozhen KANG, Ting WANG. Effect of deletion of protein 4.1R on proliferation, apoptosis and glycolysis of hepatocyte HL-7702 cells [J]. Journal of Southern Medical University, 2024, 44(7): 1355-1360.
[6]	Yuanguo WANG, Peng ZHANG. Ferroptosis suppressor genes are highly expressed in esophageal cancer to inhibit tumor cell ferroptosis [J]. Journal of Southern Medical University, 2024, 44(7): 1389-1396.
[7]	Guiling CHEN, Xiaofeng LIAO, Pengtao SUN, Huan CEN, Shengchun SHU, Bijing LI, Jinhua LI. Solasonine promotes apoptosis of non-small cell lung cancer cells by regulating the Bcl-2/Bax/caspase-3 pathway [J]. Journal of Southern Medical University, 2024, 44(6): 1109-1116.
[8]	Lingjun LU, Xiaodi YANG, Huaping ZHANG, Yuan LIANG, Xiulan SHI, Xin ZHOU. Recombinant Schistosoma japonicum cystatin alleviates acute liver injury in mice by inhibiting endoplasmic reticulum stress, inflammation and hepatocyte apoptosis [J]. Journal of Southern Medical University, 2024, 44(6): 1126-1134.
[9]	Caiyu SHEN, Shuai WANG, Ruiying ZHOU, Yuhe WANG, Qin GAO, Xingzhi CHEN, Shu YANG. Prediction of risk of in-hospital death in patients with chronic heart failure complicated by lung infections using interpretable machine learning [J]. Journal of Southern Medical University, 2024, 44(6): 1141-1148.
[10]	Guoxin LIANG, Hongyue TANG, Chang GUO, Mingming ZHANG. MiR-224-5p overexpression inhibits oxidative stress by regulating the PI3K/Akt/FoxO1 axis to attenuate hypoxia/reoxygenation-induced cardiomyocyte injury [J]. Journal of Southern Medical University, 2024, 44(6): 1173-1181.
[11]	Ruibo LI, Ge GAO, Xi XIE, Haibin LUO. Oral submucosal fibrosis induced by active components in areca nut: a network pharmacology-based analysis and validation of the mechanism [J]. Journal of Southern Medical University, 2024, 44(5): 930-940.
[12]	LI Yunfei, YANG Jingyi, ZHANG Ying, ZHANG Caixia, WEI Yuxiang, WANG Yiying, WU Ning, SUN Jianfei, WU Zunqiu. The Miao medicine Sidaxue alleviates rheumatoid arthritis in rats possibly by downregulating matrix metalloproteinases [J]. Journal of Southern Medical University, 2024, 44(4): 739-747.
[13]	CHEN Junjie, HUANG Chuanbing, LI Ming. Jianpi Zishen granule inhibits podocyte autophagy in systemic lupus erythematosus: a network pharmacology and clinical study [J]. Journal of Southern Medical University, 2024, 44(3): 465-473.
[14]	ZHANG Xiaoyan, WANG Xie, WANG Jie, SHAO Nan, CAI Biao, XIE Daojun. Huangpu Tongqiao Capsule improves cognitive impairment in rats with Wilson disease by inhibiting endoplasmic reticulum stress-mediated apoptosis pathway [J]. Journal of Southern Medical University, 2024, 44(3): 447-454.
[15]	CHEN Guodong, LUO Suxin. Colchicine alleviates myocardial ischemia-reperfusion injury in mice by activating AMPK [J]. Journal of Southern Medical University, 2024, 44(2): 226-235.